J&J Rebuffs Settlement Talks In Patent Dispute With Boston Scientific
Johnson & Johnson has rebuffed an offer to begin settlement talks by rival Boston Scientific in their patent dispute over drug-coated stents, Boston Scientific told the Boston Globe....To view the full article, register now.
Already a subscriber? Click here to view full article